Paul M. Carvey, Ph.D. - Publications

Pharmacology Rush University Medical Center, Chicago, IL, United States 

109 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any innacuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2014 Kousik SM, Napier TC, Ross RD, Sumner DR, Carvey PM. Dopamine receptors and the persistent neurovascular dysregulation induced by methamphetamine self-administration in rats. The Journal of Pharmacology and Experimental Therapeutics. 351: 432-9. PMID 25185214 DOI: 10.1124/jpet.114.217802  0.8
2014 Kelly LP, Carvey PM, Keshavarzian A, Shannon KM, Shaikh M, Bakay RA, Kordower JH. Progression of intestinal permeability changes and alpha-synuclein expression in a mouse model of Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 29: 999-1009. PMID 24898698 DOI: 10.1002/mds.25736  0.8
2014 Kousik SM, Carvey PM, Napier TC. Methamphetamine self-administration results in persistent dopaminergic pathology: implications for Parkinson's disease risk and reward-seeking. The European Journal of Neuroscience. 40: 2707-14. PMID 24890790 DOI: 10.1111/ejn.12628  0.8
2012 Kousik SM, Napier TC, Carvey PM. The effects of psychostimulant drugs on blood brain barrier function and neuroinflammation. Frontiers in Pharmacology. 3: 121. PMID 22754527 DOI: 10.3389/fphar.2012.00121  0.8
2012 Desai Bradaric B, Patel A, Schneider JA, Carvey PM, Hendey B. Evidence for angiogenesis in Parkinson's disease, incidental Lewy body disease, and progressive supranuclear palsy. Journal of Neural Transmission (Vienna, Austria : 1996). 119: 59-71. PMID 21748523 DOI: 10.1007/s00702-011-0684-8  0.8
2012 Patel A, Toia GV, Hendey B, Carvey PM. Angiogenesis and its mechanistic implications in the pathology of neurodegenerative disorders The Blood-Brain Barrier: New Research. 43-78.  0.8
2011 Kousik SM, Graves SM, Napier TC, Zhao C, Carvey PM. Methamphetamine-induced vascular changes lead to striatal hypoxia and dopamine reduction. Neuroreport. 22: 923-8. PMID 21979424 DOI: 10.1097/WNR.0b013e32834d0bc8  0.8
2011 Patel A, Toia GV, Colletta K, Bradaric BD, Carvey PM, Hendey B. An angiogenic inhibitor, cyclic RGDfV, attenuates MPTP-induced dopamine neuron toxicity. Experimental Neurology. 231: 160-70. PMID 21703263 DOI: 10.1016/j.expneurol.2011.06.004  0.8
2009 Carvey PM, Hendey B, Monahan AJ. The blood-brain barrier in neurodegenerative disease: a rhetorical perspective. Journal of Neurochemistry. 111: 291-314. PMID 19659460 DOI: 10.1111/j.1471-4159.2009.06319.x  0.8
2009 Desai BS, Schneider JA, Li JL, Carvey PM, Hendey B. Evidence of angiogenic vessels in Alzheimer's disease. Journal of Neural Transmission (Vienna, Austria : 1996). 116: 587-97. PMID 19370387 DOI: 10.1007/s00702-009-0226-9  0.8
2009 Wang S, Yan JY, Lo YK, Carvey PM, Ling Z. Dopaminergic and serotoninergic deficiencies in young adult rats prenatally exposed to the bacterial lipopolysaccharide. Brain Research. 1265: 196-204. PMID 19236855 DOI: 10.1016/j.brainres.2009.02.022  0.8
2009 Bronstein J, Carvey P, Chen H, Cory-Slechta D, DiMonte D, Duda J, English P, Goldman S, Grate S, Hansen J, Hoppin J, Jewell S, Kamel F, Koroshetz W, Langston JW, et al. Meeting report: consensus statement-Parkinson's disease and the environment: collaborative on health and the environment and Parkinson's Action Network (CHE PAN) conference 26-28 June 2007. Environmental Health Perspectives. 117: 117-21. PMID 19165397 DOI: 10.1289/ehp.11702  0.8
2009 Ling Z, Zhu Y, Tong CW, Snyder JA, Lipton JW, Carvey PM. Prenatal lipopolysaccharide does not accelerate progressive dopamine neuron loss in the rat as a result of normal aging. Experimental Neurology. 216: 312-20. PMID 19133261 DOI: 10.1016/j.expneurol.2008.12.004  0.8
2008 Monahan AJ, Warren M, Carvey PM. Neuroinflammation and peripheral immune infiltration in Parkinson's disease: an autoimmune hypothesis. Cell Transplantation. 17: 363-72. PMID 18522239  0.8
2007 Desai BS, Monahan AJ, Carvey PM, Hendey B. Blood-brain barrier pathology in Alzheimer's and Parkinson's disease: implications for drug therapy. Cell Transplantation. 16: 285-99. PMID 17503739  0.8
2007 Zhu Y, Carvey PM, Ling Z. Altered glutathione homeostasis in animals prenatally exposed to lipopolysaccharide. Neurochemistry International. 50: 671-80. PMID 17291629 DOI: 10.1016/j.neuint.2006.12.013  0.8
2007 Zhao C, Ling Z, Newman MB, Bhatia A, Carvey PM. TNF-alpha knockout and minocycline treatment attenuates blood-brain barrier leakage in MPTP-treated mice. Neurobiology of Disease. 26: 36-46. PMID 17234424 DOI: 10.1016/j.nbd.2006.11.012  0.8
2006 Carvey PM, Punati A, Newman MB. Progressive dopamine neuron loss in Parkinson's disease: the multiple hit hypothesis. Cell Transplantation. 15: 239-50. PMID 16719059 DOI: 10.3727/000000006783981990  0.8
2006 Zhu Y, Carvey PM, Ling Z. Age-related changes in glutathione and glutathione-related enzymes in rat brain. Brain Research. 1090: 35-44. PMID 16647047 DOI: 10.1016/j.brainres.2006.03.063  0.8
2006 Ling Z, Zhu Y, Tong Cw, Snyder JA, Lipton JW, Carvey PM. Progressive dopamine neuron loss following supra-nigral lipopolysaccharide (LPS) infusion into rats exposed to LPS prenatally. Experimental Neurology. 199: 499-512. PMID 16504177 DOI: 10.1016/j.expneurol.2006.01.010  0.8
2005 Carvey PM, Zhao CH, Hendey B, Lum H, Trachtenberg J, Desai BS, Snyder J, Zhu YG, Ling ZD. 6-Hydroxydopamine-induced alterations in blood-brain barrier permeability. The European Journal of Neuroscience. 22: 1158-68. PMID 16176358 DOI: 10.1111/j.1460-9568.2005.04281.x  0.8
2005 Chen L, Cagniard B, Mathews T, Jones S, Koh HC, Ding Y, Carvey PM, Ling Z, Kang UJ, Zhuang X. Age-dependent motor deficits and dopaminergic dysfunction in DJ-1 null mice. The Journal of Biological Chemistry. 280: 21418-26. PMID 15799973 DOI: 10.1074/jbc.M413955200  0.8
2005 Collier TJ, Dung Ling Z, Carvey PM, Fletcher-Turner A, Yurek DM, Sladek JR, Kordower JH. Striatal trophic factor activity in aging monkeys with unilateral MPTP-induced parkinsonism. Experimental Neurology. 191: S60-7. PMID 15629762 DOI: 10.1016/j.expneurol.2004.08.018  0.8
2005 Carvey PM, Chen EY, Lipton JW, Tong CW, Chang QA, Ling ZD. Intra-parenchymal injection of tumor necrosis factor-alpha and interleukin 1-beta produces dopamine neuron loss in the rat. Journal of Neural Transmission (Vienna, Austria : 1996). 112: 601-12. PMID 15583962 DOI: 10.1007/s00702-004-0222-z  0.8
2004 Ling Z, Chang QA, Tong CW, Leurgans SE, Lipton JW, Carvey PM. Rotenone potentiates dopamine neuron loss in animals exposed to lipopolysaccharide prenatally. Experimental Neurology. 190: 373-83. PMID 15530876 DOI: 10.1016/j.expneurol.2004.08.006  0.8
2004 Ling ZD, Chang Q, Lipton JW, Tong CW, Landers TM, Carvey PM. Combined toxicity of prenatal bacterial endotoxin exposure and postnatal 6-hydroxydopamine in the adult rat midbrain. Neuroscience. 124: 619-28. PMID 14980732 DOI: 10.1016/j.neuroscience.2003.12.017  0.8
2003 Carvey PM, Chang Q, Lipton JW, Ling Z. Prenatal exposure to the bacteriotoxin lipopolysaccharide leads to long-term losses of dopamine neurons in offspring: a potential, new model of Parkinson's disease. Frontiers in Bioscience : a Journal and Virtual Library. 8: s826-37. PMID 12957870  0.8
2002 Kompoliti K, Adler CH, Raman R, Pincus JH, Leibowitz MT, Ferry JJ, Blasucci L, Caviness JN, Leurgans S, Chase WM, Yones LC, Tan E, Carvey P, Goetz CG. Gender and pramipexole effects on levodopa pharmacokinetics and pharmacodynamics. Neurology. 58: 1418-22. PMID 12011296  0.8
2002 Goetz CG, Carvey PM, Pappert EJ, Vu TQ, Leurgans SE. The role of the serotonin system in animal models of myoclonus. Advances in Neurology. 89: 244-8. PMID 11968451  0.8
2002 Lipton JW, Vu TQ, Ling Z, Gyawali S, Mayer JR, Carvey PM. Prenatal cocaine exposure induces an attenuation of uterine blood flow in the rat. Neurotoxicology and Teratology. 24: 143-8. PMID 11943502 DOI: 10.1016/S0892-0362(01)00209-4  0.8
2002 Gayle DA, Ling Z, Tong C, Landers T, Lipton JW, Carvey PM. Lipopolysaccharide (LPS)-induced dopamine cell loss in culture: roles of tumor necrosis factor-alpha, interleukin-1beta, and nitric oxide. Brain Research. Developmental Brain Research. 133: 27-35. PMID 11850061 DOI: 10.1016/S0165-3806(01)00315-7  0.8
2002 Ling Z, Gayle DA, Ma SY, Lipton JW, Tong CW, Hong JS, Carvey PM. In utero bacterial endotoxin exposure causes loss of tyrosine hydroxylase neurons in the postnatal rat midbrain. Movement Disorders : Official Journal of the Movement Disorder Society. 17: 116-24. PMID 11835448 DOI: 10.1002/mds.10078  0.8
2001 Carvey PM, Ling ZD, Sortwell CE, Pitzer MR, McGuire SO, Storch A, Collier TJ. A clonal line of mesencephalic progenitor cells converted to dopamine neurons by hematopoietic cytokines: a source of cells for transplantation in Parkinson's disease. Experimental Neurology. 171: 98-108. PMID 11520124 DOI: 10.1006/exnr.2001.7735  0.8
2001 Storch A, Paul G, Csete M, Boehm BO, Carvey PM, Kupsch A, Schwarz J. Long-term proliferation and dopaminergic differentiation of human mesencephalic neural precursor cells. Experimental Neurology. 170: 317-25. PMID 11476598 DOI: 10.1006/exnr.2001.7706  0.8
2001 McGuire SO, Ling ZD, Lipton JW, Sortwell CE, Collier TJ, Carvey PM. Tumor necrosis factor alpha is toxic to embryonic mesencephalic dopamine neurons. Experimental Neurology. 169: 219-30. PMID 11358437 DOI: 10.1006/exnr.2001.7688  0.8
2001 Carvey PM, McGuire SO, Ling ZD. Neuroprotective effects of D3 dopamine receptor agonists. Parkinsonism & Related Disorders. 7: 213-223. PMID 11331189 DOI: 10.1016/S1353-8020(00)00061-4  0.8
2001 Kompoliti K, Goetz CG, Vu TQ, Carvey PM, Leurgans S, Raman R. Estrogen supplementation in the posthypoxic myoclonus rat model. Clinical Neuropharmacology. 24: 58-61. PMID 11290883 DOI: 10.1097/00002826-200101000-00010  0.8
2001 Chen S, Carvey PM. Structure elucidation of four related substances in gramicidin with liquid chromatography/mass spectromy Rapid Communications in Mass Spectrometry. 15: 128-134. PMID 11180541 DOI: 10.1002/1097-0231(20010130)15:2<128::AID-RCM205>3.0.CO;2-O  0.8
2001 Bennett J.P. J, Carvey PM, Hinds TR, Johnson RD, Le WD, Phillips W, Sethy VH, Vincenzi FF, Youdim MBH. Mechanisms of action of pramipexole: Putative neuroprotective effects Reviews in Contemporary Pharmacotherapy. 12: 33-57.  0.8
2000 Kordower JH, Emborg ME, Bloch J, Ma SY, Chu Y, Leventhal L, McBride J, Chen EY, Palfi S, Roitberg BZ, Brown WD, Holden JE, Pyzalski R, Taylor MD, Carvey P, et al. Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease. Science (New York, N.Y.). 290: 767-73. PMID 11052933 DOI: 10.1126/science.290.5492.767  0.8
2000 Vu TQ, Ling ZD, Ma SY, Robie HC, Tong CW, Chen EY, Lipton JW, Carvey PM. Pramipexole attenuates the dopaminergic cell loss induced by intraventricular 6-hydroxydopamine. Journal of Neural Transmission (Vienna, Austria : 1996). 107: 159-76. PMID 10847557  0.8
2000 Goetz CG, Vu TQ, Carvey PM, Leurgans S. Posthypoxic myoclonus in the rat: natural history, stability, and serotonergic influences. Movement Disorders : Official Journal of the Movement Disorder Society. 15: 39-46. PMID 10755271  0.8
2000 Storch A, Blessing H, Bareiss M, Jankowski S, Ling ZD, Carvey P, Schwarz J. Catechol-O-methyltransferase inhibition attenuates levodopa toxicity in mesencephalic dopamine neurons Molecular Pharmacology. 57: 589-594. PMID 10692500  0.8
2000 Ling ZD, Collier TJ, Sortwell CE, Lipton JW, Vu TQ, Robie HC, Carvey PM. Striatal trophic activity is reduced in the aged rat brain. Brain Research. 856: 301-9. PMID 10677639 DOI: 10.1016/S0006-8993(00)01945-4  0.8
1999 Lipton JW, Ling Z, Vu TQ, Robie HC, Mangan KP, Weese-Mayer DE, Carvey PM. Prenatal cocaine exposure reduces glial cell line-derived neurotrophic factor (GDNF) in the striatum and the carotid body of the rat: implications for DA neurodevelopment. Brain Research. Developmental Brain Research. 118: 231-5. PMID 10611525 DOI: 10.1016/S0165-3806(99)00127-3  0.8
1999 Chen S, Carvey PM, Li K. Characterization of the molecular species of phosphatidylethanolamine from kidney of the fresh water snail Lymneae stagnalis by mass spectrometry. Rapid Communications in Mass Spectrometry : Rcm. 13: 2416-2423. PMID 10567943 DOI: 10.1002/(SICI)1097-0231(19991215)13:23<2416::AID-RCM807>3.0.CO;2-V  0.8
1999 Chen S, Carvey PM. Rapid approach to the quantitative determination of topiramate (2, 3:4,5-bis-O-(1-methylethylidene)-beta-D-fructopyranose sulfamate) in human plasma by liquid-liquid extraction and flow-injection negative-ion electrospray mass spectrometry. Rapid Communications in Mass Spectrometry : Rcm. 13: 1980-4. PMID 10510408 DOI: 10.1002/(SICI)1097-0231(19991030)13:20<1980::AID-RCM741>3.0.CO;2-C  0.8
1999 Chen S, Li Q, Carvey PM, Li K. Analysis of 9-fluorenylmethyloxycarbonyl derivatives of catecholamines by high performance liquid chromatography, liquid chromatography/mass spectrometry and tandem mass spectrometry. Rapid Communications in Mass Spectrometry : Rcm. 13: 1869-77. PMID 10482902 DOI: 10.1002/(SICI)1097-0231(19990930)13:18<1869::AID-RCM731>3.0.CO;2-H  0.8
1999 Potter ED, Ling ZD, Carvey PM. Cytokine-induced conversion of mesencephalic-derived progenitor cells into dopamine neurons. Cell and Tissue Research. 296: 235-46. PMID 10382268 DOI: 10.1007/s004410051285  0.8
1999 Ling ZD, Robie HC, Tong CW, Carvey PM. Both the antioxidant and D3 agonist actions of pramipexole mediate its neuroprotective actions in mesencephalic cultures. The Journal of Pharmacology and Experimental Therapeutics. 289: 202-10. PMID 10087005  0.8
1999 Friedman JH, Goetz CG, Pappert EJ, Blasucci LM, Stebbins GT, Carvey PM. Intravenous levodopa in hallucinating PD patients [6] (multiple letters) Neurology. 52: 219-220. PMID 9921891  0.8
1999 Pappert EJ, Goetz CG, Vu TQ, Ling ZD, Leurgans S, Raman R, Carvey PM. Animal model of posthypoxic myoclonus: effects of serotonergic antagonists. Neurology. 52: 16-21. PMID 9921842  0.8
1999 Dodel RC, Du Y, Bales KR, Ling Z, Carvey PM, Paul SM. Caspase-3-like proteases and 6-hydroxydopamine induced neuronal cell death. Brain Research. Molecular Brain Research. 64: 141-8. PMID 9889353 DOI: 10.1016/S0169-328X(98)00318-0  0.8
1999 Levant B, Ling ZD, Carvey PM. Dopamine D3 receptors: Relevance for the drug treatment of Parkinson's disease Cns Drugs. 12: 391-402.  0.8
1998 Lipton JW, Robie HS, Ling Z, Weese-Mayer DE, Carvey PM. Uterine Position Determines the Extent of Dopamine Reduction after Chronic Prenatal Cocaine Exposure. Annals of the New York Academy of Sciences. 844: 314-323. PMID 29090821 DOI: 10.1111/j.1749-6632.1998.tb08246.x  0.8
1998 Lipton JW, Robie HC, Ling Z, Weese-Mayer DE, Carvey PM. The magnitude of brain dopamine depletion from prenatal cocaine exposure is a function of uterine position. Neurotoxicology and Teratology. 20: 373-82. PMID 9697963 DOI: 10.1016/S0892-0362(97)00143-8  0.8
1998 Dodel RC, Du Y, Bales KR, Ling ZD, Carvey PM, Paul SM. Peptide inhibitors of caspase-3-like proteases attenuate 1-methyl-4-phenylpyridinum-induced toxicity of cultured fetal rat mesencephalic dopamine neurons. Neuroscience. 86: 701-7. PMID 9692710 DOI: 10.1016/S0306-4522(98)00154-7  0.8
1998 Lipton JW, Robie HS, Ling Z, Weese-Mayer DE, Carvey PM. Uterine position determines the extent of dopamine reduction after chronic prenatal cocaine exposure. Annals of the New York Academy of Sciences. 844: 314-23. PMID 9668689 DOI: 10.1111/j.1749-6632.1998.tb08246.x  0.8
1998 Pappert EJ, Goetz CG, Stebbins GT, Belden M, Carvey PM. 5-Hydroxytryptophan-induced myoclonus in guinea pigs: mediation through 5-HT1/2 receptor subtypes. European Journal of Pharmacology. 347: 51-6. PMID 9650847 DOI: 10.1016/S0014-2999(98)00086-7  0.8
1998 Ling ZD, Tong CW, Carvey PM. Partial purification of a pramipexole-induced trophic activity directed at dopamine neurons in ventral mesencephalic cultures. Brain Research. 791: 137-45. PMID 9593863 DOI: 10.1016/S0006-8993(98)00088-2  0.8
1998 Ling ZD, Potter ED, Lipton JW, Carvey PM. Differentiation of mesencephalic progenitor cells into dopaminergic neurons by cytokines. Experimental Neurology. 149: 411-23. PMID 9500954 DOI: 10.1006/exnr.1998.6715  0.8
1998 Goetz CG, Pappert EJ, Blasucci LM, Stebbins GT, Ling ZD, Nora MV, Carvey PM. Intravenous levodopa in hallucinating Parkinson's disease patients: high-dose challenge does not precipitate hallucinations. Neurology. 50: 515-7. PMID 9484386  0.8
1997 Cedarbaum JM. Stability of levodopa/carbidopa solutions. Movement Disorders : Official Journal of the Movement Disorder Society. 12: 625. PMID 9251095  0.8
1997 Pappert EJ, Lipton JW, Goetz CG, Ling ZD, Stebbins GT, Carvey PM. The stability of carbidopa in solution. Movement Disorders : Official Journal of the Movement Disorder Society. 12: 608-10. PMID 9251084 DOI: 10.1002/mds.870120421  0.8
1997 Carvey PM, Pieri S, Ling ZD. Attenuation of levodopa-induced toxicity in mesencephalic cultures by pramipexole. Journal of Neural Transmission (Vienna, Austria : 1996). 104: 209-28. PMID 9203083  0.8
1997 Thajeb P, Ling ZD, Potter ED, Carvey PM. The effects of storage conditions and trophic supplementation on the survival of fetal mesencephalic cells. Cell Transplantation. 6: 297-307. PMID 9171162 DOI: 10.1016/S0963-6897(97)00034-1  0.8
1997 Carvey PM, Ling ZD. The case for neuroprotection with dopamine agonists Clinical Neuropharmacology. 20: S8-S21.  0.8
1996 Lipton JW, Davidson TL, Carvey PM, Weese-Mayer DE. Prenatal cocaine: effect on hypoxic ventilatory responsiveness in neonatal rats. Respiration Physiology. 106: 161-9. PMID 8971989 DOI: 10.1016/S0034-5687(96)00075-8  0.8
1996 Pappert EJ, Goetz CG, Niederman F, Ling ZD, Stebbins GT, Carvey PM. Liquid levodopa/carbidopa produces significant improvement in motor function without dyskinesia exacerbation. Neurology. 47: 1493-5. PMID 8960733  0.8
1996 Vawter MP, Dillon-Carter O, Tourtellotte WW, Carvey P, Freed WJ. TGFbeta1 and TGFbeta2 concentrations are elevated in Parkinson's disease in ventricular cerebrospinal fluid. Experimental Neurology. 142: 313-22. PMID 8934562 DOI: 10.1006/exnr.1996.0200  0.8
1996 Pappert EJ, Tangney CC, Goetz CG, Ling ZD, Lipton JW, Stebbins GT, Carvey PM. Alpha-tocopherol in the ventricular cerebrospinal fluid of Parkinson's disease patients: dose-response study and correlations with plasma levels. Neurology. 47: 1037-42. PMID 8857741  0.8
1996 Ling ZD, Pieri SC, Carvey PM. Comparison of the neurotoxicity of dihydroxyphenylalanine stereoisomers in cultured dopamine neurons. Clinical Neuropharmacology. 19: 360-5. PMID 8829000  0.8
1996 Pappert EJ, Buhrfiend C, Lipton JW, Carvey PM, Stebbins GT, Goetz CG. Levodopa stability in solution: time course, environmental effects, and practical recommendations for clinical use. Movement Disorders : Official Journal of the Movement Disorder Society. 11: 24-6. PMID 8771063 DOI: 10.1002/mds.870110106  0.8
1996 Lipton JW, Yuengsrigul A, Ling ZD, Weese-Mayer DE, Carvey PM. Prenatal cocaine exposure and postnatal hypoxia independently decrease carotid body dopamine in neonatal rats. Neurotoxicology and Teratology. 18: 283-7. PMID 8725640 DOI: 10.1016/S0892-0362(96)90027-6  0.8
1996 Carvey PM, Lin DH, Faselis CJ, Notermann JK, Ling ZD. Loss of striatal DA innervation increases striatal trophic activity directed at DA neurons in culture. Experimental Neurology. 140: 184-97. PMID 8690061 DOI: 10.1006/exnr.1996.0128  0.8
1995 Hedges S, El-Mallakh RS, Carvey PM, Suddath RL, Wyatt RJ. Dopamine-responsive neurotrophic factor in schizophrenia. Schizophrenia Research. 18: 83-4. PMID 8929765 DOI: 10.1016/0920-9964(95)00066-6  0.8
1995 Ptak LR, Hart KR, Lin D, Carvey PM. Isolation and manipulation of rostral mesencephalic tegmental progenitor cells from rat. Cell Transplantation. 4: 335-42. PMID 7640873 DOI: 10.1016/0963-6897(95)00004-H  0.8
1994 Weese-Mayer DE, Silvestri JM, Lin D, Buhrfiend CM, Ptak LR, Lo ES, Carvey PM. Hypoxia after prenatal cocaine attenuates striatal dopamine and neurotrophic activity. Neurotoxicology and Teratology. 16: 177-81. PMID 8052192 DOI: 10.1016/0892-0362(94)90115-5  0.8
1994 Yu SJ, Lo ES, Cochran EJ, Lin DH, Faselis CJ, Klawans HL, Carvey PM. Cerebrospinal fluid from patients with Parkinson's disease alters the survival of dopamine neurons in mesencephalic culture. Experimental Neurology. 126: 15-24. PMID 7908885 DOI: 10.1006/exnr.1994.1038  0.8
1994 Kurlan R, Tanner CM, Goetz C, Sutton J, Lichter D, Carvey P, Deeley C, Cui L, Irvine C, McDermott MP. Levodopa drug holiday versus drug dosage reduction in Parkinson's disease Clinical Neuropharmacology. 17: 117-127.  0.8
1993 Goetz CG, Thelen JA, MacLeod CM, Carvey PM, Bartley EA, Stebbins GT. Blood levodopa levels and unified Parkinson's disease rating scale function: with and without exercise. Neurology. 43: 1040-2. PMID 8492923  0.8
1993 Weese-Mayer DE, Silvestri JM, Lin D, Buhrfiend CM, Lo ES, Carvey PM. Effect of cocaine in early gestation on striatal dopamine and neurotrophic activity. Pediatric Research. 34: 389-92. PMID 8134184 DOI: 10.1203/00006450-199309000-00029  0.8
1993 Carvey PM, Ptak LR, Nath ST, Sierens DK, Mufson EJ, Goetz CG, Klawans HL. Striatal extracts from patients with Parkinson's disease promote dopamine neuron growth in mesencephalic cultures. Experimental Neurology. 120: 149-52. PMID 8097475 DOI: 10.1006/exnr.1993.1049  0.8
1993 Redmond DE, Hoffer BJ. IVth International Symposium on Neural Transplantation. Transcript of the closing discussion (edited) (session 44.0). Washington, D.C.: July 16, 1992. Journal of Neural Transplantation & Plasticity. 4: 113-24. PMID 7906550 DOI: 10.1155/NP.1993.113  0.8
1993 Carvey PM, Ptak LR, Lin D, Lo ES, Buhrfiend CM, Drucker GE, Fields JZ. Alterations in striatal neurotrophic activity induced by dopaminergic drugs. Pharmacology, Biochemistry, and Behavior. 46: 195-204. PMID 7902982 DOI: 10.1016/0091-3057(93)90340-Y  0.8
1992 Kerns JM, Sierens DK, Kao LC, Klawans HL, Carvey PM. Synaptic plasticity in the rat striatum following chronic haloperidol treatment. Clinical Neuropharmacology. 15: 488-500. PMID 1335837  0.8
1991 Carvey PM, McRae A, Lint TF, Ptak LR, Lo ES, Goetz CG, Klawans HL. The potential use of a dopamine neuron antibody and a striatal-derived neurotrophic factor as diagnostic markers in Parkinson's disease. Neurology. 41: 53-8; discussion 59-. PMID 2041594  0.8
1991 Shults CW, O'Connor DT, Baird A, Hill R, Goetz CG, Watts RL, Klawans HL, Carvey PM, Bakay RA, Gage FH. Clinical improvement in parkinsonian patients undergoing adrenal to caudate transplantation is not reflected by chromogranin A or basic fibroblast growth factor in ventricular fluid. Experimental Neurology. 111: 276-81. PMID 1999231 DOI: 10.1016/0014-4886(91)90094-S  0.8
1991 Kroin JS, Kao LC, Zhang TJ, Penn RD, Klawans HL, Carvey PM. Dopamine distribution and behavioral alterations resulting from dopamine infusion into the brain of the lesioned rat. Journal of Neurosurgery. 74: 105-11. PMID 1984488 DOI: 10.3171/jns.1991.74.1.0105  0.8
1991 Carvey PM, Ptak LR, Lo ES, Lin DH, Buhrfiend CM, Goetz CG, Klawans HL. Levodopa reduces the growth promoting effects of striatal extracts on rostral mesencephalic tegmentum cultures. Experimental Neurology. 114: 28-34. PMID 1915732 DOI: 10.1016/0014-4886(91)90081-M  0.8
1990 Dahlström A, Wigander A, Lundmark K, Gottfries CG, Carvey PM, McRae A. Investigations on auto-antibodies in Alzheimer's and Parkinson's diseases, using defined neuronal cultures. Journal of Neural Transmission. Supplementum. 29: 195-206. PMID 2358801  0.8
1990 Carvey PM, Kao LC, Zhang TJ, Amdur RL, Lin DH, Singh R, Klawans HL. Dopaminergic alterations in cotreatments attenuating haloperidol-induced hypersensitivity. Pharmacology, Biochemistry, and Behavior. 35: 291-300. PMID 2320636 DOI: 10.1016/0091-3057(90)90158-E  0.8
1990 Carvey PM, McRae A, Ptak LR, Kao LC, Lo ES, Goetz CG, Tanner CM, Penn RD, Klawans HL. Disappearance of a putative DA-neuron antibody following adrenal medulla transplantation: relationship to a striatal-derived DA neuron trophic factor. Progress in Brain Research. 82: 693-7. PMID 2290972  0.8
1990 Penn RD, Kroin JS, Kroin SA, Klawans HL, Goetz CG, Tanner CM, Shannon KM, Comella CL, Carvey PM, Zhang TJ, Witt T, Wilson R, Stebbins GT, Gilley DW, Yaksh T, et al. The adrenal medullary transplant operation: The Chicago experience Progress in Brain Research. 82: 627-635. PMID 2290964  0.8
1990 Carvey PM, Nath ST, Kao LC, Zhang TJ, Lin DH, Singh R, Amdur RL, Klawans HL. Clozapine fails to prevent the development of haloperidol-induced behavioral hypersensitivity in a cotreatment paradigm. European Journal of Pharmacology. 184: 43-53. PMID 2209714 DOI: 10.1016/0014-2999(90)90665-S  0.8
1989 Carvey P, Nausieda P, Weertz R, Klhhans H. LSD and other related hallucinogens elicit myoclonic jumping behavior in the guinea pig Progress in Neuropsychopharmacology and Biological Psychiatry. 13: 199-210. PMID 2748860 DOI: 10.1016/0278-5846(89)90017-1  0.8
1989 Carvey PM, Ptak LR, Kao L, Klawans HL. Striatal homogenates from animals chronically treated with haloperidol stimulate dopamine and GABA uptake in cultures of rostral mesencephalic tegmentum. Clinical Neuropharmacology. 12: 425-34. PMID 2611766  0.8
1988 Carvey PM, Hitri A, Goetz CG, Tanner CM, Klawans HL. Concurrent treatment with benztropine and haloperidol attenuates development of behavioral hypersensitivity but not dopamine receptor proliferation. Life Sciences. 42: 2207-15. PMID 3374255 DOI: 10.1016/0024-3205(88)90372-4  0.8
1988 Goetz CG, Tanner CM, Shannon KM, Carroll VS, Klawans HL, Carvey PM, Gilley D. Controlled-release carbidopa/levodopa (CR4-Sinemet) in Parkinson's disease patients with and without motor fluctuations. Neurology. 38: 1143-6. PMID 3290706  0.8
1988 McRae-Degueurce A, Klawans HL, Penn RD, Dahlstrom A, Tanner CM, Goetz CG, Carvey PM. An antibody in the CSF of Parkinson's disease patients disappears following adrenal medulla transplantation. Neuroscience Letters. 94: 192-7. PMID 3241668 DOI: 10.1016/0304-3940(88)90294-7  0.8
1987 Carvey PM, Kao LC, Klawans HL. The effect of bilateral kainic acid-induced lateral habenula lesions on dopamine-mediated behaviors. Brain Research. 409: 193-6. PMID 3580867 DOI: 10.1016/0006-8993(87)90759-1  0.8
1987 Carvey PM, Braun AR, Kao LC, Klawans HL. Effects of dopamine antagonists and apomorphine on regional energy metabolism in rat CNS. Clinical Neuropharmacology. 10: 247-60. PMID 3454716  0.8
1986 Carvey PM, Kao LC, Tanner CM, Goetz CG, Klawans HL. The effect of antimuscarinic agents on haloperidol induced behavioral hypersensitivity. European Journal of Pharmacology. 120: 193-9. PMID 3948919 DOI: 10.1016/0014-2999(86)90540-6  0.8
1986 Klawans HL, Carvey PM, Nelson D, Tanner CM, Goetz CG. The effect of thioridazine on haloperidol induced behavioral hypersensitivity. Life Sciences. 38: 1707-14. PMID 3702600 DOI: 10.1016/0024-3205(86)90120-7  0.8
1986 Klawans HL, Carvey PM, Tanner CM, Goetz CG. Drug-induced myoclonus. Advances in Neurology. 43: 251-64. PMID 3484854  0.8
1984 Goetz CG, Carvey PM, Tanner CM, Klawans HL. Neuroleptic-induced dopamine hyposensitivity. Life Sciences. 34: 1475-9. PMID 6538629 DOI: 10.1016/0024-3205(84)90062-6  0.8
1982 Nausieda PA, Carvey PM, Braun A. Long-term suppression of central serotonergic activity by corticosteroids: a possible model of steroid-responsive myoclonic disorders. Neurology. 32: 772-5. PMID 6979722  0.8
1982 Nausieda PA, Carvey PM, Weiner WJ. Modification of central serotonergic and dopaminergic behaviors in the course of chronic corticosteroid administration. European Journal of Pharmacology. 78: 335-43. PMID 6978254 DOI: 10.1016/0014-2999(82)90035-8  0.8
1979 Weiner WJ, Carvey PM, Nausieda PA, Klawans HL. Dopaminergic antagonism of L-5-hydroxytryptophan-induced myoclonic jumping behavior. Neurology. 29: 1622-5. PMID 41197  0.8
Show low-probability matches.